Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.88 and traded as high as $0.97. Oxbridge Re shares last traded at $0.9624, with a volume of 18,273 shares.
Analysts Set New Price Targets
Separately, Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.
View Our Latest Stock Analysis on OXBR
Oxbridge Re Price Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last released its earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share (EPS) for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The business had revenue of $0.58 million for the quarter.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Virtu Financial LLC acquired a new position in Oxbridge Re during the third quarter valued at approximately $32,000. International Assets Investment Management LLC acquired a new position in Oxbridge Re during the fourth quarter valued at approximately $39,000. J.W. Cole Advisors Inc. acquired a new position in Oxbridge Re during the third quarter valued at approximately $59,000. Finally, Henrickson Nauta Wealth Advisors Inc. lifted its position in Oxbridge Re by 100.0% during the fourth quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock valued at $185,000 after buying an additional 68,700 shares in the last quarter. 5.64% of the stock is owned by institutional investors and hedge funds.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
